alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 15,301–15,325 of 27,380 studies, newest first · page 613 of 1096.

February 2017 25

  1. 2017-02-22

    Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia

    ✓ Peer-reviewed Long-term cohort studies Neurology

    Key finding: We observed 234 cases of all-cause dementia over 10 years of follow-up. +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2017-02-22

    Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications

    ✓ Peer-reviewed Prevention and risk Expert review of clinical pharmacology

    Key finding: Brain injury is associated with acute and chronic hyperglycaemia, insulin resistance, hyperinsulinemia, diabetic ketoacidosis (DKA) and hypoglycaemic events in diabetic patients.

    Full summary, score breakdown and related studies → Original source

  3. 2017-02-21

    Care home leadership: action is needed

    ✓ Peer-reviewed Health systems and care delivery Age and Ageing

    Key finding: As a result, the similarities of older people in residential care to those in nursing care homes greatly outweigh the differences and arguably strengthen the case for RN input to all care home residents.

    Full summary, score breakdown and related studies → Original source

  4. 2017-02-21

    Enhanced neural activation with blueberry supplementation in mild cognitive impairment

    ✓ Peer-reviewed Prevention and risk Nutritional neuroscience

    Key finding: Preclinical studies have shown that blueberry supplementation can improve cognitive performance and neural function in aged animals and have identified associations between anthocyanins and such benefits. +2 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2017-02-20

    A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease

    ✓ Peer-reviewed Drug development Neuropharmacology

    Key finding: We previously showed that the novel dual agonist (DA-JC1) was effective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2017-02-20

    Tau PET imaging: present and future directions

    ✓ Peer-reviewed Brain scans and imaging Molecular neurodegeneration

    Key finding: In this review, we summarize recent findings on the most promising tau PET tracers to date, discuss what has been learnt from these findings, and offer some suggestions for the next steps that need to be achieved in a near future.

    Full summary, score breakdown and related studies → Original source

  7. 2017-02-18

    Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study

    ✓ Peer-reviewed Prevention and risk The Lancet

    Key finding: Living less than 50 meters from a major road was linked to a 7% higher risk of dementia (HR 1.07) compared with living more than 300 meters away +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2017-02-17

    Effectiveness of person-centered care on people with dementia: a systematic review and meta-analysis

    ✓ Peer-reviewed Caregiving Clinical interventions in aging

    Key finding: Nineteen interventional studies, including 3,985 participants, were identified. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2017-02-17

    Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease

    ✓ Peer-reviewed Drug development Alzheimer's research & therapy

    Key finding: These results indicate that the use of statins may benefit all AD patients with potentially greater therapeutic efficacy in those homozygous for ApoE4. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2017-02-17

    Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging

    ✓ Peer-reviewed Brain scans and imaging The Journal of neuroscience : the official journal of the Society for Neuroscience

    Key finding: Normal aging is associated with a decline in episodic memory and also with aggregation of the β-amyloid (Aβ) and tau proteins and atrophy of medial temporal lobe (MTL) structures crucial to memory formation. +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2017-02-17

    Early-onset and delayed-onset poststroke dementia - revisiting the mechanisms

    ✓ Peer-reviewed Prevention and risk Nature reviews. Neurology

    Key finding: However, results from clinical trials completed in the past 10-15 years have been disappointing. +2 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2017-02-16

    Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the FOURIER trial

    ✓ Peer-reviewed Cognitive tests and assessment Clinical cardiology

    Key finding: Key additional exclusion criteria for EBBINGHAUS were dementia, cognitive impairment, or other significant mental or neurological disorder.

    Full summary, score breakdown and related studies → Original source

  13. 2017-02-16

    Soluble TREM2 induces inflammatory responses and enhances microglial survival

    ✓ Peer-reviewed TREM2 and immune genetics The Journal of experimental medicine

    Key finding: A soluble form of TREM2 (sTREM2) derived from proteolytic cleavage of the cell surface receptor is increased in the preclinical stages of AD and positively correlates with the amounts of total and phosphorylated tau in the cerebrospinal fluid. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2017-02-16

    From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution

    ✓ Peer-reviewed Mild cognitive impairment Neuropsychiatric disease and treatment

    Key finding: Evidence from cross-sectional and longitudinal studies has shown that MCI is associated with an increased risk of positive AD biomarkers and an increased annual conversion rate of 5%-17% to AD. +2 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2017-02-16

    Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective

    ✓ Peer-reviewed Prevention and risk Acta diabetologica

    Key finding: Given the frequency with which T2D and AD occur, the notion that people with T2D may be at increased risk for AD has large societal consequences, and understanding the mechanistic links between these diseases is imperative for the development of effective AD prevention and treatment strategies. +3 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2017-02-15

    Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals

    ✓ Peer-reviewed Brain scans and imaging Brain

    Key finding: In this study, we first assessed the patterns of brain tau tangle accumulation (measured with the positron emission tomography tracer 18F-AV-1451) associated with well-established Alzheimer's disease factors in a cohort including cognitively healthy elderly individuals and individuals at early symptomatic stages of Alzheimer's disease. +2 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2017-02-15

    Approach to atypical Alzheimer's disease and case studies of the major subtypes

    ✓ Peer-reviewed Risk factors CNS spectrums

    Key finding: Our knowledge of atypical clinical phenotypes of AD comes from clinicopathologic studies, but with the growing use of in vivo molecular biomarkers of amyloid and tau pathology, we are beginning to recognize that these syndromes may not be as rare as once thought. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2017-02-15

    Multicenter Validation of an MMSE-MoCA Conversion Table

    ✓ Peer-reviewed Cognitive tests and assessment Journal of the American Geriatrics Society

    Key finding: Accumulating evidence points to the superiority of the MoCA over the MMSE as a cognitive screening tool. +3 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2017-02-14

    Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases

    ✓ Peer-reviewed Brain scans and imaging Japanese journal of radiology

    Key finding: Activity of the glymphatic system may be evaluated with diffusion images. +1 more finding

    Full summary, score breakdown and related studies → Original source

  20. 2017-02-14

    n-3 Fatty acids, Mediterranean diet and cognitive function in normal aging: A systematic review

    ✓ Peer-reviewed Prevention trials Experimental gerontology

    Key finding: Studies suggest that n-3 fatty acids in the diet and adherence to the MedDiet are beneficial in slowing age-related cognitive decline. +4 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2017-02-14

    Deconstructing empathy: Neuroanatomical dissociations between affect sharing and prosocial motivation using a patient lesion model

    ✓ Peer-reviewed Long-term cohort studies Neuropsychologia

    Key finding: We used a neurodegenerative disease (NDG) lesion model to examine the neural correlates of these two aspects of real-world empathic responding. +3 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2017-02-14

    Nutrition and dementia care: developing an evidence-based model for nutritional care in nursing homes

    ✓ Peer-reviewed Digital health tools BMC geriatrics

    Key finding: This collaboratively developed, person-centred model can support the design of new education and training tools and be readily translated into existing programmes. +1 more finding

    Full summary, score breakdown and related studies → Original source

  23. 2017-02-13

    Human astrocytes in the diseased brain

    ✓ Peer-reviewed Down syndrome and Alzheimer's Brain research bulletin

    Key finding: These findings, together with the discovery that human astrocytes display contrasting characteristics with their rodent counterparts, point to a role for astrocytes in higher cognitive functions.

    Full summary, score breakdown and related studies → Original source

  24. 2017-02-13

    Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer's Disease

    ✓ Peer-reviewed Disease mechanisms Molecules (Basel, Switzerland)

    Key finding: Here, we provide evidence that grape skin and grape seed extracts increase the inhibition effect on Aβ aggregation. +4 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2017-02-13

    Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease

    ✓ Peer-reviewed Disease mechanisms Molecular therapy : the journal of the American Society of Gene Therapy

    Key finding: Previous studies have shown that HDAC2 expression is strongly increased in Alzheimer's disease (AD), a major neurodegenerative disorder and the most common form of dementia. +1 more finding

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →